Chan, E. D., Strand, M. J., & Iseman, M. D. (2009). Multidrug-resistant tuberculosis (TB) resistant to fluoroquinolones and streptomycin but susceptible to second-line injection therapy has a better prognosis than extensively drug-resistant TB. Clinical infectious diseases, 48(5), e50. https://doi.org/10.1086/597010
Citace podle Chicago (17th ed.)Chan, Edward D., Matthew J. Strand, a Michael D. Iseman. "Multidrug-resistant Tuberculosis (TB) Resistant to Fluoroquinolones and Streptomycin but Susceptible to Second-line Injection Therapy Has a Better Prognosis than Extensively Drug-resistant TB." Clinical Infectious Diseases 48, no. 5 (2009): e50. https://doi.org/10.1086/597010.
Citace podle MLA (9th ed.)Chan, Edward D., et al. "Multidrug-resistant Tuberculosis (TB) Resistant to Fluoroquinolones and Streptomycin but Susceptible to Second-line Injection Therapy Has a Better Prognosis than Extensively Drug-resistant TB." Clinical Infectious Diseases, vol. 48, no. 5, 2009, p. e50, https://doi.org/10.1086/597010.